HIKAL
Hikal Share Price
Hikal Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Hikal Investment Rating
-
Master Rating:
-
Hikal has an operating revenue of Rs. 1,864.73 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 11% is healthy, ROE of 15% is good. The company has a reasonable debt to equity of 27%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 6% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 64 which is a FAIR score but needs to improve its earnings, a RS Rating of 1 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
- Indicator
- Jun 2022
- Mar 2022
- Dec 2021
- Sep 2021
- Jun 2021
- Mar 2021
- Oper Rev Qtr Cr
- 371
- 501
- 515
- 469
- 455
- 532
- Operating Expenses Qtr Cr
- 356
- 441
- 422
- 378
- 361
- 423
- Operating Profit Qtr Cr
- 23
- 61
- 93
- 91
- 96
- 109
- Depreciation Qtr Cr
- 27
- 24
- 25
- 24
- 23
- 22
- Interest Qtr Cr
- 11
- 8
- 7
- 8
- 8
- 10
- Tax Qtr Cr
- -3
- 8
- 16
- 16
- 18
- 30
- Net Profit Qtr Cr
- -9
- 21
- 45
- 44
- 51
- 51
Hikal Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 10
- Bearish Moving Average
- ___
- 6
- 20 Day
- 260.21
- 50 Day
- 273.45
- 100 Day
- 315.15
- 200 Day
- 396.79
- 20 Day
- 259.14
- 50 Day
- 253.71
- 100 Day
- 326.05
- 200 Day
- 397.08
Hikal Resistance and Support
- First Resistance
- 276.74
- Second Resistance
- 286.47
- Third Resistance
- 302.19
- First Resistance
- 251.29
- Second Resistance
- 235.57
- Third Resistance
- 225.84
- RSI
- 57.46
- MFI
- 74.39
- MACD Single Line
- 0.12
- MACD
- 2.12
Hikal Delivery and Volume
- Period
- NSE + BSE
Volume Avg - NSE + BSE
Delivery Volume Avg - NSE + BSE
Delivery Volume %
- Day
- 555,299
- 25,499,330
- 45.92
- Week
- 741,287
- 34,299,361
- 46.27
- 1 Month
- 474,926
- 21,124,728
- 44.48
- 6 Month
- 510,806
- 19,757,987
- 38.68
Hikal Result Highlights
Hikal Synopsis
NSE-Medical-Diversified
Hikal Ltd. is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1720.44 Cr. and Equity Capital is Rs. 24.66 Cr. for the Year ended 31/03/2021. Hikal Ltd. is a Public Limited Listed company incorporated on 08/07/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1988PTC048028 and registration number is 048028.- Market Cap
- 3,333
- Sales
- 1,865
- Shares in Float
- 3.82
- No of funds
- 62
- Yield
- 0.59
- Book Value
- 3.12
- U/D Vol ratio
- 1
- LTDebt / Equity
- 27
- Alpha
- -0.36
- Beta
- 1.14
Hikal
- Owner Name
- Jun-22
- Mar-22
- Dec-21
- Sep-21
- Promoters
- 68.77%
- 68.77%
- 68.77%
- Mutual Funds
- 0.77%
- 0.76%
- 0.23%
- Insurance Companies
- 0.12%
- 0.12%
- 0.12%
- Foreign Portfolio Investors
- 3.91%
- 6.92%
- 6.91%
- Individual Investors
- 18.54%
- 18.06%
- 18.51%
- Others
- 7.89%
- 5.37%
- 5.46%
Hikal Management
- Name
- Designation
- Mr. Jai Hiremath
- Chairman & Managing Director
- Mr. Sameer Hiremath
- Joint Managing Director & CEO
- Ms. Sugandha Hiremath
- Director
- Mrs. Shivani Sachdeva
- Director
- Mr. Ranjit Shahani
- Director
- Mr. Kannan Unni
- Director
- Mr. Amit Kalyani
- Director
- Mr. Baba Kalyani
- Director
- Mr. Prakash Mehta
- Director
- Mr. Ravindra Kumar Goyal
- Director
Hikal Forecast
Price Estimates
Hikal Corporate Action
- Date
- Purpose
- Remarks
- 2022-08-10
- Quarterly Results
- 2022-05-28
- Audited Results & Final Dividend
- 2022-02-14
- Quarterly Results & Interim Dividend
- 2021-10-26
- Quarterly Results
- 2021-08-05
- Quarterly Results
- Date
- Purpose
- Remarks
- 2022-02-24
- INTERIM
- Rs.1.20 per share(60%)Interim Dividend
- 2021-08-26
- FINAL
- Rs.1.00 per share(50%)Final Dividend
- 2021-02-16
- INTERIM
- Rs.1.00 per share(50%)Interim Dividend
Hikal FAQs
What is Share Price of Hikal ?
Hikal share price is ₹271 As on 16 August, 2022 | 09:20
What is the Market Cap of Hikal ?
The Market Cap of Hikal is ₹3347 Cr As on 16 August, 2022 | 09:20
What is the P/E ratio of Hikal ?
The P/E ratio of Hikal is 33.1 As on 16 August, 2022 | 09:20
What is the PB ratio of Hikal ?
The PB ratio of Hikal is 3.1 As on 16 August, 2022 | 09:20